Stopped: lack of funding
This is an open-label, non-randomized study. Volunteers will be vaccinated with the oral cholera vaccine, Vaxchora. Vaxchora has been licensed by the Food and Drug Administration (FDA) for travelers to developing countries. Volunteers will also be asked to provide blood specimens over a follow-up time period of up to eight years. The specimens obtained in this clinical research study will be used to further the investigator's understanding of the protective immunological mechanisms that can be elicited systemically and may be applicable to other enteric pathogens.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in the Absolute Percentage of Positive CD4+ CD25+/OX40+ T Cells
Timeframe: Baseline and Day 3
Change in Absolute Percentage of Positive CD4+ CD25+/OX40+ T Cells
Timeframe: Baseline and Day 5
Change in Absolute Percentage of Positive CD4+ CD25+/OX40+ T Cells
Timeframe: Baseline and Day 8
Change in Absolute Percentage of Positive CD4+ CD25+/OX40+ T Cells
Timeframe: Baseline and Day 10
Change in Absolute Percentage of Positive CD4+ CD25+/OX40+ T Cells
Timeframe: Baseline and Day 15
Change in Absolute Percentage of Positive CD4+ CD25+/OX40+ T Cells
Timeframe: Baseline and Day 29
Change in Absolute Percentage of Positive T Follicular/Helper 17 Cells Expressing CD154
Timeframe: Baseline and Day 1
Change in Absolute Percentage of Positive T Follicular/Helper 17 Cells Expressing CD154
Timeframe: Baseline and Day 3
Change in Absolute Percentage of Positive T Follicular/Helper 17 Cells Expressing CD154
Timeframe: Baseline and Day 5
Change in Absolute Percentage of Positive T Follicular/Helper 17 Cells Expressing CD154
Timeframe: Baseline and Day 8
Change in Absolute Percentage of Positive T Follicular/Helper 17 Cells Expressing CD154
Timeframe: Baseline and Day 10
Change in Absolute Percentage of Positive T Follicular/Helper 17 Cells Expressing CD154
Timeframe: Baseline and Day 15
Change in Absolute Percentage of Positive T Follicular/Helper 17 Cells Expressing CD154
Timeframe: Baseline and Day 29